Welcome to our dedicated page for American Well SEC filings (Ticker: AMWL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on American Well's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into American Well's regulatory disclosures and financial reporting.
American Well Corp Chief Accounting Officer Paul Francis McNeice reported an open-market sale of 653 shares of Class A common stock at $9.33 per share on July 1, 2026. According to the footnote, this automatic “sell to cover” trade was made solely to pay taxes on vested restricted stock units and was not a discretionary transaction. After the sale, he directly held 9,851 shares.
American Well Corp Chief Financial Officer Mark Hirschhorn reported a tax-related sale of 4,299 shares of Class A Common Stock. The shares were sold in an open-market transaction at $9.33 per share.
According to the disclosure, the sale was an automatic “sell to cover” transaction to pay tax liabilities from the vesting and settlement of restricted stock units on July 1, 2026, and did not represent a discretionary trade. After the sale, Hirschhorn directly owned 238,939 shares, indicating he retained the vast majority of his holdings.
American Well Corp’s Chief Product & Technology Officer, Dmitry Zamansky, sold 8,460 shares of Class A Common Stock at $9.33 per share. According to the filing, the sale was an automatic “sell to cover” transaction to pay taxes from restricted stock units vesting on July 1, 2026, and was not a discretionary trade. After the transaction, he directly holds 232,620 shares.
American Well Corp President, International Phyllis Gotlib reported an automatic sale of Class A Common Stock to cover taxes from vested restricted stock units. On July 1, 2026, 6,677 shares were sold in the open market at $9.33 per share through a non-discretionary “sell to cover” transaction.
After this sale, Gotlib directly holds 152,754 Class A shares. In addition, 114,920 Class A shares are reported as indirectly owned through her husband. The filing reflects a tax-related transaction rather than a discretionary change in investment exposure.
American Well Corporation filed a Form 144 reporting Class A Common Stock related to restricted stock unit vesting effective 07/01/2026. The notice identifies 6,301 RSUs vesting on 07/01/2026 and discloses prior sales of 10,761 shares on 06/01/2026 for $104,800.30.
American Well Corporation filed a Form 144 reporting proposed sales tied to a restricted stock unit vesting and a recent disposition. The filing lists 18,132 shares from a 07/01/2026 RSU vesting and notes 5,575 shares sold on 04/01/2026 for $29,563.67.
American Well Corporation filed a Form 144 reporting the vesting of 12,679 Restricted Stock Units of Class A Common Stock effective 07/01/2026. The filing also lists prior small dispositions by Phyllis Gotlib: 3,573 shares on 06/01/2026 and 3,706 shares on 04/01/2026.
American Well Corporation held its 2026 annual meeting of stockholders on June 16, 2026. Stockholders elected Class III director Dr. Ido Schoenberg, who received 20,509,462 votes for and 954,941 withheld, with 2,507,946 broker non-votes, to serve until the 2029 annual meeting.
Stockholders also ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, with 23,945,239 votes for and 27,110 withheld. In a non-binding advisory vote, stockholders approved the named executive officer compensation, with 21,137,741 votes for, 326,662 withheld, and 2,507,946 broker non-votes.
Cosgrove Delos M. reported acquisition or exercise transactions in this Form 4 filing.
American Well Corp director Delos M. Cosgrove received an equity grant in the form of restricted stock units. The award covers 14,501 shares of Class A Common Stock at no cash cost and increases his direct holdings to 71,193 shares. The RSUs vest on the earlier of the day immediately preceding the first annual stockholders’ meeting following the grant date or the first anniversary of the grant date, linking compensation to continued board service.
Webb Robert Thomas reported acquisition or exercise transactions in this Form 4 filing.
American Well Corp director Robert Thomas Webb received an equity grant of 14,501 shares of Class A Common Stock in the form of restricted stock units. The award was granted at no cash cost to him and is compensation-related, not an open-market purchase.
These restricted stock units vest on the earlier of the day immediately preceding the first annual stockholder meeting following the grant date or the first anniversary of the grant date. After this grant, Webb directly holds 72,559 shares of Class A Common Stock, indicating the transaction is modest relative to his total reported holdings.